Pharma Industry News

Acumen shares positive results for investigational Alzheimer’s disease therapy at AAIC

The results will be discussed with regulators to assess next steps for clinical development

Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]